4.4 Article

Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial

Journal

AIDS
Volume 26, Issue 14, Pages 1745-1753

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0b013e328357724f

Keywords

correlates of protection; herpes simplex virus; HIV infection; interferon-gamma; natural killer cells; tenofovir gel

Funding

  1. South African HIV/AIDS Research Platform (SHARP)
  2. US National Institutes for Health [FIC K01-TW007793]
  3. United States Agency for International Development (USAID) [FHI360, GPO-A-00-05-00022-00, 132119]
  4. Technology Innovation Agency (LIFElab) of the South African government's Department of Science and Technology
  5. CONRAD, Eastern Virginia Medical School [GP00-08-00005-00, PPA-09-046]
  6. US National Institutes for Health's Comprehensive International Program of Research on AIDS [AI51794]
  7. LIFELab
  8. Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP) [D43 TW000231]
  9. Massachusetts General Hospital Physician Scientist Development Award

Ask authors/readers for more resources

Objective: To assess the role of natural killer (NK) cells in HIV acquisition. Design: We conducted a nested case-control substudy to the Center for the AIDS Programme of Research in South Africa (CAPRISA004) tenofovir gel trial. Methods: Thirty women who acquired HIV infection (cases) and 30 women with high-risk sexual activity who remained HIV-negative (controls) were selected. Proliferation, degranulation and interferon-gamma (IFN-gamma) secretion were measured by multiparametric flow cytometry after culture of recombinant human interleukin-2 (rhIL-2)-activated peripheral blood mononuclear cells with 721.221 cells or in-vitro HIV-infected, autologous CD4(+) T-cell blasts. Relationships between pre-acquisition NK cell responses and HIV acquisition were modeled with logistic regression models. Results: NK cells from cases had lower IFN gamma responses to human leukocyte antigen-deficient 721.221 cells than controls (median %IFN gamma posNK cells: 13.7 vs. 21.6%, P=0.03). rhIL-2-activated NK cells from cases had responses to autologous HIV-infected target cells distinct from controls: cases had fewer proliferating and more frequent degranulating NK cells. NK cells from cases had significantly lower IFN-gamma responses to in-vitro HIV-infected autologous T cells than controls even after adjusting for responses to uninfected blasts (median %IFN gamma posNK-cells: 0.53 vs. 2.09%, P=0.007). Responses to in-vitro HIV-infected autologous T cells were significantly lower in herpes simplex virus 2 (HSV-2)-infected women (P=0.003). IFN gamma NK cell responses to autologous HIV-infected cells were associated with lower risk of HIV acquisition (odds ratio adjusted for age, gel arm, HSV-2 and immune activation: 0.582, 95% confidence interval 0.347-0.977, P=0.04). Conclusion: At the time of exposure to HIV, women with impaired NK cell IFN gamma responses were more likely to acquire HIV infection. NK cells, as early responders to viral exposure, were associated with lower risk of HIV acquisition, independent of the intercalated effect of HSV-2 infection suppressing NK cell responses. (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available